Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia

Abstract

We found gene variants which may become early predictors of the therapy outcome and allow development of new early prognostic tests for estimation of therapy efficacy in CML patients. Normal genetic variation may influence therapy efficacy during targeted treatment of cancers.